Trials / Recruiting
RecruitingNCT06893484
Assessment of Early Pregnancy MAB Completion
Assessing Completion of Medication Abortion for Very Early Pregnancies
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- University of Washington · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrolled participants will take take weekly pregnancy tests and complete weekly questionnaires on their pregnancy symptoms for 4 weeks after their medication abortion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Weekly high-sensitivity urine pregnancy tests | Participants will take a high-sensitivity urine pregnancy test at home weekly for up to 4 weeks compared to the taking just one home urine pregnancy test at 4-5 weeks. Participants will also complete short weekly questionnaires on their pregnancy symptoms and follow-up care. |
Timeline
- Start date
- 2025-03-13
- Primary completion
- 2026-03-01
- Completion
- 2026-04-01
- First posted
- 2025-03-25
- Last updated
- 2025-06-05
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06893484. Inclusion in this directory is not an endorsement.